[vc_row][vc_column width=”2/3″][vc_column_text]

Economic costs

Estimating the components of the costs associated with ASD helps to characterize the needs of individuals and assess the overall impact of future new educational, social or health care and other policies or interventions. Getting a better understanding of costs can help decision makers to weigh the relative merits of different ways to utilize, prioritize and allocate available resources.

The first ever study of the overall costs of ASD was conducted by Järbrink and Knapp (2001) for the UK, and studies for other countries or for specific aspects of treatment or support have followed. The most recent and comprehensive estimates compare the UK and USA.

Several authors reported that expenditures associated with ASD have substantially increased across time, due to improved diagnosis, services availability and use. In each of these studies, data were obtained from several sources including previous literature, population surveys, private health insurance plans and interviews with individuals with ASD, family and other carers, and service professionals.

Costing information is higly valuable for planning longer term projections of the resources needed to support people with ASD under a range of alternative scenarios.[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_text_separator title=”Posters & Communications”][vc_column_text]

XI Autism Europe International Congress 2016
16-18 September, 2016 in Edinburgh

Cost of illness in autism: a revision of methods


Download Poster

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”2/3″][vc_column_text]References

  1. Järbrink, K., & Knapp, M. (2001). The economic impact of autism in Britain. Autism: The International Journal of Research and Practice, 5(1), 7-22.

  2. Ganz, M. L. (2007). The lifetime distribution of the incremental societal costs of autism. Archives of Pediatrics & Adolescent Medicine, 161(4), 343-349. doi:10.1001/archpedi.161.4.343

  3. Liptak GS, Stuart T, Auinger P (2006) Health care utilization and expenditures for children with autism: data from U.S. national samples. Journal of Autism and Developmental Disorders. 36(7):871-9.

  4. Knapp, M., Romeo, R., & Beecham, J. (2009). Economic cost of autism in the UK. Autism: The International Journal of Research and Practice, 13(3), 317-336. doi:10.1177/1362361309104246

  5. Buescher A, Cidav Z, Knapp M, Mandell D (2014) Costs of autism spectrum disorders in the United Kingdom and United States of America. Journal of the American Medical Association Pediatrics. 168 (8): 721-8.

  6. Leslie DL, & Martin A. (2007). HEalth care expenditures associated with autism spectrum disorders. Archives of Pediatrics & Adolescent Medicine, 161(4), 350-355. doi:10.1001/archpedi.161.4.350

  7. Shimabukuro, T. T., Grosse, S. D.,& Rice, C. (2008). Medical Expenditures for Children with an Autism Spectrum Disorder in a Privately Insured Population. Journal of Autism and Developmental Disorders, 38(3), 546-552. doi:10.1007/s10803-007-0424-y

  8. Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. (2006) A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large groupmodel health plan. Pediatrics. 118(4):e1203-11.

  9. Baxter, AJ., Brugha TS., Erskine HE., Scheurer RW., Vos T. and Scott JG. (2014). The epidemiology and global burden of autism spectrum disorders. Psychological Medicine, 1-13

[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_single_image image=”622″ img_size=”360×270″ alignment=”center”][vc_column_text]Painting by Elbio Fernández Sara. Person diagnosed of autism.[/vc_column_text][/vc_column][/vc_row]